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THE last decade has witnessed an exponential growth of 
information in the field of biological macromolecules 
such as proteins and nucleic acids and their interactions 
with other molecules. Computational analysis and predictions 
based on such information are increasingly becoming an 
essential and integral part of modern biology. With rapid 
advances in the area, there is a growing need to develop 
versatile bioinformatics software packages, which are effi-
cient and incorporate the latest developments in this field. 
In view of this, the Council of Scientific and Industrial 
Research, India, undertook an initiative to promote a unique 
industry–academia collaboration, to develop a compre-
hensive bioinformatics software package, under its New 
Millennium Initiative for Technology Leadership in India 
programme. BioSuite, a product of that effort, has been 
developed by Tata Consultancy Services who took the 
primary coding responsibility with significant backing 
from a large academic community who participated on 
advisory roles through the project period. 
 BioSuite integrates the functions of macromolecular 
sequence and structural analysis, chemoinformatics and 
algorithms for aiding drug discovery. The suite organized 
into four major modules, contains 79 different programs, 
making it one of the few comprehensive suites that caters 
to a major part of the spectrum of bioinformatics applica-
tions. The four major modules, (a) Genome and proteome 
sequence analysis, (b) 3D modelling and structural analysis, 
(c) Molecular dynamics simulations and (d) Drug design, 
are made available through a convenient graphics-user in-
terface along with adequate documentation and tutorials. 
The unique partnership with academia has also ensured 
that the best available methodology has been adopted for each 
of the 79 programs, which has been thoroughly evaluated 
in several stages, leading to high scientific value of the 
suite. The software, apart from having the advantage of 
running on a Linux platform on a personal computer, is 
also flexible, modular, and allows for newer algorithms to 
be plugged into the overall framework. The package will 
be valuable for high quality academic research, industrial 
research and development and for teaching purposes, both 
locally within the country as well as in the international 
arena. A full list of the programs as well as their example 
usage can be found at  http://www.atc.tcs.co.in/bioinfo/ 
publications/biosuite_paper.pdf. 
Background 
Genesis of BioSuite 
The Council of Scientific and Industrial Research (CSIR), 
Government of India, proposed a new millennium initia-
tive for technology leadership in India (NMITLI), in 2000, 
wherein India could acquire leadership positions in key 
technology areas (NMITLI). Development of versatile, 
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Table 1.
 Roles played by different groups for ensuring successful development of BioSuite 
Algorithm design, Code writing, Coding quality checks, Graphic-user Tata Consultancy Services, team led by M. Vidyasagar  
 interfaces and performance benchmarking  Sharmila Mande and Rajagopal Srinivasan 
Algorithm/module design suggestions and scientific evaluations Academic partners 
Project monitoring committee R. Narasimha, G. Padmanaban, G. R. Desiraju, D. Balasubramanian 
Project co-ordination  Yogeswara Rao and Vibha Sawhney, CSIR 
Project funding CSIR, NMITLI Scheme, Govt of India 
Manuscript preparation Coordinated by Nagasuma Chandra and Saraswathi Vishveshwara, IISc 
 
 
portable bioinformatics software was recognized as one 
such area, taking into account the expertise available in 
the Indian academic community. Such a project, promoted 
by CSIR, was therefore flagged off in partnership with 
the industry, where Tata Consultancy Services (TCS) took 
the major responsibility of developing the BioSuite soft-
ware with significant scientific support from the major 
academic institutions in the country (Table 1). The objec-
tives of the project have been to develop indigenously, a 
set of software tools, that would assist the academic re-
search, R&D and applications in industry, in the rapidly 
emerging field of bioinformatics and rational drug design.  
 The need for such a software suite is exemplified by 
two main factors: (a) increase in bioinformatics activities 
at all levels – education, research, industry, rapid growth 
of primary data and methods in computational biology 
and (b) limitations of existing suites – such as very high 
cost and not being comprehensive under a single frame-
work, as discussed later. A team of 35 members from TCS 
worked on this project.  
Mode of operation 
To ensure the smooth functioning of the project, the fol-
lowing management structure was put in place: (a) A 
Monitoring Committee, monitored the progress of the 
project through periodic meetings with TCS and the aca-
demic partners providing timely focus, (b) A Steering 
Committee, consisting of scientists from academic institu-
tions and TCS, coordinated the activities of the group, (c) 
Domain experts and consultants, consisting of all acade-
mic partners, helped in arriving at a basic structure for the 
suite. Given the large size of the group and the involve-
ment of 18 institutions, the efforts from CSIR and the 
monitoring committees have played a significant role in 
fostering the unique partnership to ensure success of this 
project. The domain experts have advised TCS on the in-
dividual modules and individual programs required in 
each module, identified appropriate algorithms at each 
step, as also the features required for each program, as 
per the current research trends and requirements. Further, 
(d) a team of pseudo-code developers of six people at 
TCS, have interacted with domain experts and directed 
their (e) in-house team of code developers, consisting of 
27 software engineers, who have written the actual code. 
The (f) Software Project Management Committee from 
TCS has ensured the overall activities at that end and en-
sured appropriate benchmarking and in-house quality 
checks from the software perspective. The scientific per-
formance of the codes developed has been further evalu-
ated by the academic partners, who have tested and repor-
ted bugs to Project Management Committee, after which 
the codes have been improved/modified where required. 
Further, an autonomous assessment of the suite has been 
obtained by an independent expert in the area. 
Operational schedules 
A glimpse of the schedules and the various milestones 
reached are given below: (a) Identification of the modules, 
the required programs in each module and the appropriate 
algorithm(s) for each program, was completed in the first 
four months, following which a (b) Software Requirement 
Specification (SRS) document was developed and revie-
wed in the next two months. Next, the pseudo-codes were 
developed in about five months and converted into final 
code in the next 12 months. In parallel with alpha-testing 
that was carried out simultaneously with code develop-
ment, the documentation and creation of a user guide took 
about seven months. Bug reporting and bug fixes were car-
ried out in iterations through the testing phases and a 
beta-version was produced by June 2004, taking a total of 
24 months. Evaluation and bug fixing of this version was 
carried out in five months, leading to the first full ver-
sion, soft-launched in July 2004 and product released in 
December 2004. 
Overview of the organization of the suite  
The entire package, consisting of 79 different programs is 
organized into four major modules, all linked through 
three common graphics-user interface (GUI) workbenches, 
as illustrated in Figure 1. The four modules are: (a) Genome 
and sequence analysis, (b) 3D modelling and structure 
analysis, (c) Molecular dynamics simulations and (d) Drug 
design. They are accessible through central GUIs for file 
handling, sequence and structure windows.  
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Figure 1. Modular organization of BioSuite. 
 
 
Table 2. Examples of programs contained in the modules 
Sequence and genome analysis 
Genome sequence assembly and EST mapping1, ePCR2, ORF prediction3, Intron–exon boundary4, Database search5 and sequence align-
ments (pairwise6,7; multiple8; whole genome alignment9); Motifs and patterns (restriction sites10, motif building and searching11; primer and 
probe design12); RNA and protein secondary structure and transmembrane prediction13–15; Domain building and searching16, gene order17, 
unique genes18; Phylogenetic analysis, tree construction, evolutionary distance estimation and profiling19–21. 
Structural analysis 
Nucleic acid analysis22, protein structure quality check23, symmetry-related molecules, structural superposition24, interactions25, homology 
modelling and threading26; Fold classification27; Molecular surface area, solvent accessible surface area and volume28; Binding site detec-
tion (PASS29; ET30).  
Simulations 
Energy minimizations (steepest descent31 and conjugate gradient minimizers32; forcefields33); Electrostatic potential maps34,35; Molecular 
dynamics36,37; MD analysis of various trajectories, RMSD, average position and plots of system properties. 
Drug design 
Structure-based design using protein–ligand docking38; Conformation search39; Steric and electrostatic ligand alignment40; QSAR with over 
80 descriptors and regression analysis; Pharmacophore identification and pharmacophore-based search41,42. 
 
 
 Table 2 lists the important programs in each module. A 
full list of the modules as well as example outputs of the 
individual programs can be found at http://www.atc. 
tcs.co.in/bioinfo/publications/biosuite_paper.pdf. Combi-
nation of the four modules makes BioSuite a comprehen-
sive package, covering much of the activities of the 
bioinformatics spectrum, starting from genome sequences 
to individual and multiple protein sequences, different 
levels of structure prediction, analysis of the structures, 
molecular mechanics calculations, molecular dynamics 
simulations, chemoinformatics and finally integration 
with the application of the sequence and structural analy-
ses in rational drug design through algorithms for QSAR, 
pharmacophore identification and docking processes, for 
facilitating rational drug design. 
Choice of algorithms and coding methods 
Choice of algorithms was discussed extensively with aca-
demic partners and the latest concepts available in the lit-
erature have been adopted wherever possible. For some 
programs, more than one algorithm has also been imple-
mented, to suit the current research trends of using multiple 
methods and studying consensus predictions. In general, 
about two scientists have analysed and chosen a particular 
algorithm for a particular purpose. Table 2 indicates the 
algorithms chosen for each of the programs. The knowl-
edge and description of each of the algorithms have been 
captured into detailed SRS documents by the pseudo-code 
development team at TCS through extensive interactions 
with the academic partners as well as with a detailed study 
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of the appropriate literature. The pseudo-code generated 
for each algorithm and its linkages have been developed 
using formal software engineering methods, so as to 
guarantee correctness. The pseudo-code was then conver-
ted into actual code by another set of programers who 
have ensured strict adherence to well-established quality 
processes such as CMMi Level 5.  
 All codes have been written in C++. A total of 170 algo-
rithms and about 100 QSAR descriptor calculators have 
been implemented in 79 programs, with about 700,000 
lines of code. The suite is modular, which not only facili-
tates seamless updation of the modules but also enables 
integration of new programs by the end users.  
Description of the modules  
The functionalities of the programs contained within the 
four major modules are briefly described below.  
Genome and proteome sequence analysis 
This module deals with the applications relating to the 
analysis of the nucleic acid and protein sequences, not only 
of individual molecules, but also of complete genome and 
proteome sequences. This module would enable researchers 
to annotate genomes, predict protein secondary structures, 
derive a phylogenetic relationship among organisms and 
compare two genomes for similarities at the gene or protein 
level, along with a range of other applications. This module 
is further divided into four sub-modules: Sequence analysis, 
genome analysis, Comparative genomics and Utilities.  
 Sequence analysis of individual molecules is enabled 
through the sequence analysis modules, while the pro-
grams in the ‘Genome analysis’ sub-module enable com-
parison and analysis of full genomes and proteomes. Two 
database searching tools, BLAST and PSI-BLAST are in-
terfaced with the suite, that will enable searching data-
bases to identify a given sequence or find conserved 
domains or even find distantly related homologues from 
some other species. An option of building custom-made 
databases is also provided. Alignment of sequences, a 
crucial task in sequence analysis, is provided for, through 
two well-established algorithms for global and local 
alignments using dynamic programing algorithms (Nee-
dleman–Wunsch and Smith–Waterman). Further, a hier-
archical clustering-based multiple alignment algorithm 
(ClustalW) is included for aligning a set of sequences. 
Besides, pattern identification and matching tasks such as 
finding composition, inverted repeats, DNA structure motifs, 
restriction site analysis and repeat analysis, are part of 
this module.  
 Algorithms for secondary structure prediction including 
transmembrane region detection, RNA structure predic-
tion and analysis are also part of this module. The secon-
dary structure prediction algorithms were trained (or re-
trained as appropriate) using a comprehensive dataset 
containing 731 high resolution protein structures (with 
resolutions ≤ 2 Å) that comprise a non-redundant dataset 
(redundancy has been removed through sequence com-
parisons, using a similarity cut-off of 25% with the Blo-
sum62 substitution matrix). Use of a large dataset in 
training the prediction algorithms ensures high prediction 
accuracy. A comprehensive biophysical parameter com-
putation ability has also been built into BioSuite, by ex-
tracting 36 different physico-chemical properties for 
protein molecules from the dataset and subsequently using 
them as training-sets in the prediction algorithms. Algori-
thms for predicting isoelectric point, peptide cleavage 
patterns, B-cell antigenicity from protein sequences are 
also included in this module. Yet another useful feature 
of this module is the domain building and analysing func-
tionality. Programs are available for identifying domains, 
building consensus domain sequences, calibrating them 
and searching across a database. Hidden Markov models 
using sequence profiles are used for these purposes. In 
addition, the module has programs for studying molecular 
evolution, to cluster groups of sequences based on several 
criteria and to compute phylogenetic trees as well as to 
calculate evolutionary distances. Finally, algorithms for 
gene finding, gene assembly, probe and primer design, 
vector trimming and EST analysis are also part of this 
module. Two examples of using the programs of this 
module are illustrated in Figure 2 a and b. 
3D Modelling and analysis 
The 3D modelling and analysis module has capabilities to 
build, analyse and predict three-dimensional structures of 
macromolecules and macromolecular complexes. This 
module is further subdivided into the following sub-
modules: (a) Homology modelling, (b) Threading, (c) 
Building proteins, (d) Building nucleic acids, (e) Building 
carbohydrates, (f) Generation of symmetry-related mole-
cules, (g) Structural superposition, (h) Surfaces and volumes, 
(i) Binding site analysis, (j) Nucleic acid analysis, (k)  
Interactions, (l) Quality check, and (m) Fold detection. 
Example snapshots are shown in Figure 2 c and d. 
 Building the models of protein molecules by predicting 
their three-dimensional structures by comparative modelling 
techniques are enabled through the first two sub-modules, 
for which six algorithms are available that incorporate the 
latest concepts in these areas. Building nucleic acids and 
carbohydrates using geometric information is enabled 
through the building modules. A notable feature of the 
builder programs is the incorporation of 17 geometrical 
templates for nucleic acids and 12 templates for carbohy-
drates providing a handle to address the stereo-chemical 
variability in a large number of sugars. Several programs 
that can address visualization and analysis of crystallo-
graphically derived structures are also included in this 
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module. For example, a lattice assembly of a protein 
molecule, as seen in its crystal structure can be generated 
easily. Structure validation tools for proteins and nucleic 
acids are enabled through the quality check programs. 
Extensive analysis is possible through the analysis and 
interactions functions, that can be used for analysing in-
tegral features of protein structure, protein–protein inter-
actions as well as protein–ligand interactions. Finally, 
algorithms for classifying protein structures, in relation to 
the other protein structures known in the literature, are 
also included in this module through the fold detection 
routines. Here too, the unique integration of building, 
 
 
Figure 2. (Contd…) 
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Figure 2 a–h. Example snapshots from various modules of BioSuite: a, Genome comparison: Mapping Protein gi|42525869, from Bacillus halo-
rudians
 to Clusters of Orthologous Groups (COG no. 1893), by using orthologues. A homologue of a lipase from Treponema denticola gi|42525869 
was identified from Bacillus halorudians; b, Protein secondary structure prediction using different methods and property profiles derived for the 
lipase protein sequence; c, Different molecular representations in BioSuite – (a) ball-and-stick, (b) cartoons, (c) molecular surface, (d) van der 
Waals surface, (e) space fill, (f) C-alpha trace, (g) sticks, (h) ribbons, (i) solvent accessible surface; d, Protein structure quality check using a 
Ramachandran plot; e, An example of MD-analysis, variation in kinetic energy, potential energy, total energy, temperature during simulation; f, An 
example of pharmacophore fitting, g, Alignments produced by BioSuite derived pharmacophore model, and h, An example of a field fit alignment: 
Molecular similarity between a pair of molecules is calculated by using the Gaussian function in BioSuite. 
 
 
analysis and structural bioinformatics tools such as structure 
classification, all within one framework, significantly en-
hances the technical value of BioSuite. 
Simulations 
The ‘simulations’ module essentially simulates the be-
haviour of a molecule, in terms of its three-dimensional 
structure. The different submodules covered are, Force-
field, Energy minimization, Molecular dynamics, Monte 
Carlo simulations and Electrostatics. The molecular simu-
lation of a system can conceptually be broken into three 
components: (a) generating a computational description 
of a biological/chemical system typically in terms of atoms, 
molecules and associated force field parameters, (b) the 
numerical solution of the equations which govern their 
evolution, and (c) the application of statistical mechanics 
to relate the behaviour of a few individual atoms/mole-
cules to the collective behaviour of the very many. 
BioSuite is compatible both with the AMBER and the 
CHARMM force fields for macromolecules (proteins, nu-
cleic acids and carbohydrates) and uses GAFF for small 
molecules (for e.g. natural substrates, drugs and drug-like 
substances). For each of the force fields, both treatments 
of the type of dielectric: either constant or distant depen-
dent, are provided.
 
 Several algorithms for first-order unconstrained energy 
minimization are contained in this module, providing a 
wide range of line search options. Thus, the coordinates 
of the molecular system can be adjusted so as to lower its 
energy, relative to the starting conformation, by using one 
of the following minimizers: Steepest descent algorithm, 
Conjugate gradient methods, Fletcher–Reeves algorithm, 
Polak–Ribiere algorithm, Polak–Ribiere plus algorithm 
and Shanno’s algorithm. 
 Further, to carry out molecular dynamics (MD) simula-
tions, BioSuite provides NVE (micro-canonical), NVT 
(canonical), and NPT (isobaric–isothermal) ensembles for 
MD simulations with the choice of using velocity–verlet 
or leapfrog integrator. BioSuite also provides options for 
using SHAKE and RATTLE constraints. 
 MD being a deterministic approach, where the state of 
the system at any future time can be predicted from its 
current state, the tools provided in the suite can be used 
for solving Newton’s equations of motion for a given ini-
tial conformation, to study how the system evolves over 
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time. Several intuitive and user-friendly tools are provided 
to analyse the resulting trajectories or time series of con-
formations. For example (Figure 2 e), plots at various en-
ergy levels along with the temperature, can be obtained. 
Plots generated with defined parameters show the structure 
and position at various energy levels, both of them pre-
sent in two adjacent panels that can help to view the posi-
tion of the molecule at a given temperature. The Monte 
Carlo method that generates configurations randomly and 
uses a special set of criteria to decide whether or not to 
accept each new configuration, is also part of this module. 
 In the electrostatics sub-module, BioSuite provides a 
solution for the linear Poisson–Boltzmann equation, to 
enable modelling of contributions of solvent, counterions 
and protein charges to electrostatic fields in molecules. 
Four choices for boundary conditions namely, zero, partial 
coulombic, full coulombic and focusing, are provided. 
For charge distribution, there are two options: trilinear 
and uniform. BioSuite has a very fast SOR solver, which 
utilizes spectral radius calculations to speed up convergence.  
Drug design 
This module provides the following functionalities: (a) 
Prediction of biological activities of unknown chemical 
entities using QSAR, (b) Identification of pharmacopho-
res in biologically active molecules, (c) Superimposition 
of a set of molecules in 3D space by alignment, (d) Iden-
tification of the ligand poses in 3D space when it binds to 
a target using docking. Using the functionalities provided 
in the drug design module, one can identify lead-like 
molecules from a set of molecules, redesign them and 
predict their activities. Thus, lead optimization can be 
achieved iteratively. If the target structure is known, then 
the lead optimization can be done using the structure-based 
method, such as by docking. 
 The process of aligning a set of molecules in three-
dimensional space, to find the superimposable regions of 
a group of molecules or to estimate molecular similarity 
can be performed by using either the ‘Field Fitting’ or the 
‘RMS Fitting’ approach. The field fitting is done by 
aligning molecules using their electrostatic potentials and 
steric shapes, starting from their atomic coordinates and 
charges computed from Gaussian functions, while the 
‘RMS fitting’ is done by minimizing the distances bet-
ween specified atoms in the molecules. Flexible superpo-
sition can also be achieved by allowing rotations about 
single bonds. 
 For deriving and matching ‘3D-pharmacophores’, the 
following features are extracted/used: (a) Hydrogen bond 
donor, (b) Hydrogen bond acceptor, (c) Aliphatic hydro-
phobic group, (d) Aromatic ring, (e) Negatively charged 
group, and (f) Positively charged group. Pharmacophores 
are identified by using configurations of features common 
to a set of molecules. The pharmacophoric configurations 
are identified by a pruned exhaustive search, starting with 
small sets of features and extending them until no larger 
common configuration exists. 
 To carry out QSAR, where consistent relationships bet-
ween the variations in the values of molecular properties 
and the biological activity for a series of compounds are 
sought, so that these ‘rules’ can be used to evaluate new 
chemical entities, a series of widely accepted feature ex-
traction and statistical tools are provided within BioSuite. 
For example, a 2D-QSAR calculation uses either one or 
combinations of (a) Electronic, (b) Spatial, (c) Structural, 
(d) Thermodynamic and (e) Topological descriptors. 
BioSuite has the ability to compute 89 different descriptors. 
a few representative descriptors from different classes, 
e.g. Polarizability, HOMO and LUMO (electronic), Hf 
and Log P from (thermodynamic), log P, MR (thermody-
namic), etc. and were compared with those computed from 
standard softwaers, using a dataset of 33 isooxazoles as 
potential thrombin receptor antagonists and in general, a 
high correlation (>0.9) was observed for the descriptor 
values. 
 Creating and refining a training set required for QSAR 
predictions are aided by (a) K-means, (b) K-nearest 
neighbours or (c) UPGMA hierarchical clustering algo-
rithms. Tools are also provided for building user-defined 
data sets/training sets as well as for searching chemical 
databases. The QSAR model can be generated using re-
gression techniques such as Multiple Linear Regression 
or Partial Least Squares. If the linearly independent de-
scriptors for the molecules have to be eliminated while 
generating the model, then a dimensionality reduction can 
be performed by using either (a) Principal component 
analysis or (b) Discriminant analysis. Validation of the 
model to check the accuracy of the generated model can 
be performed by the K-fold cross validation technique 
 The structure-based drug design sub-module contains 
algorithms and utilities required for carrying out molecular 
docking. Using either simulated annealing or genetic al-
gorithms (GA) based technique, the ligand conformations 
are searched and docked into the binding site of the macro-
molecule. In a simulated annealing-based method, the 
ligand’s current position, orientation and conformation 
are changed during each cycle, to reach the most energe-
tically favourable conformation of the ligand bound to the 
target macromolecule. Thus these algorithms predict both 
the lowest energy conformation of the bound ligand as 
well as the best position and orientation for its binding to 
the target molecule, within the realm of the scientific ca-
pabilities of the approach. 
 A second popular algorithm is provided for this, the 
one based on genetic algorithms. The conformations of the 
ligand are encoded as a chromosome. The crossover and 
mutation operators are used to bring about random 
changes in the conformations of the ligand. A fitness function 
is defined for calculating the energy of the conformations 
generated. Through a number of runs of the GA cycle, a 
conformation having minimum energy is obtained.  
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 Conformation search functionality generates the con-
formations for an input molecule, clusters the conforma-
tions and displays energy and torsion angle values of low 
energy conformations. This application generates confor-
mations using two different methods, namely random 
conformation search and systematic conformation search. 
The random conformation search uses the simulated an-
nealing algorithm. An option is provided to the user to se-
lect the rotatable bonds in the molecule. A few sample 
results from the drug-design modules are presented in 
Figure 2 f–h. 
Performance evaluation 
Evaluation has been an integral part of the entire deve-
lopment process. To start with, the choice of modules and 
the choice of algorithms themselves were evaluated, both 
at TCS and by the academic partners. The pseudo-codes 
and the SRS documents were then verified, followed by 
verification of the software codes by the TCS team. The 
scientific performance of the algorithms at various stages 
(versions 0.3, 0.7, 1.0a and 1.0) was evaluated independ-
ently by the academic partners at their institutions and 
any bugs reported or improvements suggested were sub-
sequently considered and implemented into the suite, 
where appropriate. The outputs of each program were 
compared with those of other established academic codes/ 
commercial packages, to verify the scientific performance. 
They were also compared with the latest implementations 
of the chosen algorithms in the public domain, where 
available. The performance has been found to be compa-
rable in all cases. While the utilities of many of the indi-
vidual programs have been enhanced while implementing 
in BioSuite, the scientific capabilities and limitations of 
each of the programs are bounded by those of the corre-
sponding original algorithms cited in Table 2.  
 An example of the manner in which the scientific per-
formance was evaluated, is cited below. For testing the 
drug design module, 42 thymidine monophosphate kinase 
inhibitors were taken and minimization performed using 
both AMBER and CHARMM force fields with the conju-
gate gradient algorithm method. Conformational searches 
were tested with both systematic and randomized search 
methods. Alignments were satisfactory and we obtained 
low RMSD values for similar molecules, comparable to 
those obtained in Cerius. The time for computation was 
found to be good and comparable to other competitor 
software. The docking procedure is simple and user-
friendly.  
Prominent features of the package 
For the most part, the existing software packages evolved 
out of academia, and were implementations of algorithms 
developed at different places and different times by dif-
ferent persons. As such, often there is no single ‘super-
structure’ into which the algorithms fit seamlessly. To 
overcome these issues, BioSuite has been written in a 
modular fashion, which would permit the easy implemen-
tation of new algorithms as and when they are discovered. 
The unique partnership of the industry with academia 
harnesses the strengths of both communities, thus leading 
to a superior product both scientifically as well as according 
to software engineering standards. Some of the unique 
features of BioSuite are: (a) It is comprehensive, contains 
programs for carrying out sequence, whole genome and 
structure analysis, drug design, all under a common 
framework. (b) The software runs on simple personal 
computers on a Linux platform. (c) Domain identification 
and domain searching tools also available. (d) Trans-
membrane beta strand prediction, enhanced capability in 
building molecules in terms of the number of secondary 
structure templates available. (e) Enhanced capability in 
building larger carbohydrate structures, and (f) Code 
written fresh with CMMi-5 standards and consistency in 
coding methods to incorporate versatility in each program 
making up the entire suite, keeping in view of the genome-
scale operations in bioinformatics. 
Roadmap for the future 
Going forward, several features are planned to be added 
to BioSuite to make it an even more useful platform for 
scientific research. Some developments in the pipeline 
are described below: 
ADME 
The Absorption, Distribution, Metabolism and Excretion 
profile (ADME) of a drug is an important determinant of 
its therapeutic efficacy. Accurately modelling the ADME 
properties of a candidate drug molecule is a necessary 
step to increase the chances that it will eventually become 
a successful drug. In the recent past, models have been 
developed for estimating various ADME-related proper-
ties such as blood-brain barrier penetration, human intes-
tinal absorption, binding affinity to human serum albumin 
and CaCO2 cell permeability. These will be integrated 
into the existing QSAR module of BioSuite. 
Flexible docking 
Docking, in BioSuite 1.0, explores the energetically opti-
mal fit of a flexible small molecule with a rigid protein 
molecule. In subsequent releases, an improved version of 
the docking algorithm will be implemented that allows 
restricted flexibility in the protein molecule as well. This 
has been shown to be useful in improving the accuracy in 
prediction of the optimal binding conformation. 
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De novo drug design 
An important requirement for drug design is the ability to 
generate novel molecules that bind to a known active site. 
Implementation of an algorithm is underway for the gene-
ration of novel binding candidates using a strategy of frag-
ment docking followed by elaboration of selected fragments. 
tRNA identification 
A procedure for identifying tRNA genes in a genome will 
be included in the next version of BioSuite. The program 
identifies tRNAs based on the recognition of two intra-
genic control regions known as A and B boxes, a highly 
conserved part of B box, a transcription termination signal, 
and the evaluation of the spacing between these elements. 
Improved whole genome comparison 
MUMmer is an open source software package for the 
rapid alignment of very large DNA and amino acid se-
quences. A newer version of the MUMmer package has 
been integrated in BioSuite to find maximal unique 
matches between two genomes. The MUMmer output can 
also be viewed in the dot-plot format.  
Improved graphics 
Several techniques are being implemented to enhance the 
quality of the 3D graphics display in BioSuite while 
speeding up the display. 
Scripting interface 
While BioSuite provides a number of features and a vast 
array of functionality, users might want to implement their 
own procedures and programs. For this purpose, a script-
ing interface that exposes the functionality in BioSuite 
will be provided so that users can create their own workflows, 
develop and test new ideas and automate several tasks. 
Sketcher 
The next version of Bio-Suite will include a 2D sketcher 
for drawing molecules in a manner that chemists are famil-
iar with and to automatically generate 3D structures for 
the molecules.  
 A high-performance version called Bio-Cluster for some 
of the memory intensive applications is also planned. 
Hardware requirements and documentation 
The minimum hardware requirements for BioSuite are as 
follows: Intel compatible ×86 Processor, 1.5 GHz, 256 MB 
RAM, 3 GB Free Hard Disk Space, Display capable of 
1280 × 1024 pixel resolution, High end graphics card 
with 3D support for better viewing, Red-Hat Linux 8.0 or 
9.0 or Fedora-Core 1/2 operating systems. BioSuite comes 
with its own set of documentation. The entire package is 
well documented and comes with easy to use tutorials, 
which reduce the learning curve and increase efficiency. 
Detailed documentation is available at the BioSuite web-
site: http://www.atc.tcs.co.in/BioSuite/. 
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